|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Red day on Monday for Adaptimmune Therapeutics plc stock after losing 0%
(Updated on Nov 17, 2025)
No changes to the price of Adaptimmune Therapeutics plc stock on the last trading day (Monday, 17th Nov 2025). During the last trading day the stock fluctuated 0% from a day low at $0.0549 to a day high of $0.0549. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0287 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.09% during the next 3 months and, with a 90% probability hold a price between $0.0296 and $0.230 at the end of this 3-month period.
ADAP Signals & Forecast
There are mixed signals in the stock today. The Adaptimmune Therapeutics plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0549 and $0.101. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, October 27, 2025, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Adaptimmune Therapeutics plc stock
Adaptimmune Therapeutics plc finds support from accumulated volume at $0.0526 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%
Our recommended stop-loss: $0.0516 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 15 days ago.)
Trading Expectations (ADAP) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Adaptimmune Therapeutics plc to open at $0.0549, and during the day (based on 14 day Average True Range), to move between $0.0489 and $0.0609, which gives a possible trading interval of +/-$0.0119 (+/-24.41%) up or down from last closing price. If Adaptimmune Therapeutics plc takes out the full calculated possible swing range there will be an estimated 24.41% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.0526 (4.19%) than the resistance at $0.0590 (7.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Adaptimmune Therapeutics plc stock A Buy?
Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $0.0549 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ADAP Performance
Trading levels for ADAP
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0549 | - |
| R2 | 0.0549 | - |
| R1 | 0.0549 | - |
| Price | 0.0549 | |
| S1 | 0.0549 | - |
| S2 | 0.0549 | - |
| S3 | 0.0549 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0666 | 21.31% |
| R2 | 0.0597 | 8.74% |
| R1 | 0.0590 | 7.47% |
| Price | 0.0549 | |
| S1 | 0.0526 | -4.19% |
| S2 | 0.0510 | -7.10% |
| S3 | 0.0486 | -11.48% |
FAQ
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.
Buy ADAP
A buy signal from a double bottom formation was found on Friday, August 22, 2025 and based on theory for this formation the price should go up by 9.84% to $0.0603 within 2 trading days (Tuesday, August 26, 2025) since signal was issued.